Rocket Lab’s Alaskan Outpost: How a $266 Million Hypersonics Deal Rewrites the Defense Playbook
Published on 07/28/2026 at 00:30 | Redaktion boerse-global.de
Rocket Lab’s stock has been battered — down nearly 57% from its May peak and off 23% in the past month alone — but the company just signed a contract that fundamentally reshapes its relationship with the Pentagon. The $266 million award from the US Space Force’s Rocket Systems Launch Program is the largest single launch contract in the firm’s history, and it comes with a geographic twist that could prove as significant as the dollar figure.
The deal, first awarded on July 21 but officially confirmed this Monday, covers up to 18 suborbital missions: 12 firm launches with an option for six more. Rocket Lab will build a new launch site at the Pacific Spaceport Complex in Kodiak, Alaska, adding a fourth operational pad to its existing facilities in New Zealand and Virginia. The missions will fly on HASTE — a modified Electron rocket designed specifically for hypersonic and missile defense testing, capable of exceeding Mach 20 and carrying payloads up to 700 kilograms.
CEO Peter Beck framed the award as validation of the Pentagon’s appetite for high-cadence, repeatable launch capability. “Cadence and iteration are critical for national security,” Beck said, noting that the Space Force is betting on Rocket Lab’s ability to deliver hypersonic and missile defense tests at frequency. The contract runs through the end of 2028, with the first mission expected no earlier than late 2026. Of the total, $112 million is already committed from the fiscal year 2025 research budget.
The stock responded with a modest gain — up 3.01% in German trading to €58.10, following a close of €56.40 on Friday. That’s a welcome respite after a brutal stretch, but the move hardly signals a turning tide. The monthly decline still stands at 21.80%, and the gap to the 52-week high of €133.80, reached in late May, remains a punishing 56.58%. The relative strength index sits at 32.1, deep in oversold territory, while annualized volatility runs at a hair-raising 88.20%.
Should investors sell immediately? Or is it worth buying Rocket Lab?
A Backlog That Tells a Different Story
For investors focused on the chart, the narrative is one of exhaustion. But the order book offers a contrasting view. The Space Force contract alone represents roughly 12.1% of Rocket Lab’s total backlog of $2.2 billion — a figure that already includes five firm launches for the upcoming Neutron rocket. The Pentagon award broadens the company’s defense exposure in a way that single-mission contracts never could.
Analysts remain broadly bullish, with a consensus buy rating and an average price target of $105.71 (or €100.51), implying theoretical upside of more than 75% from current levels. The disconnect between retail selling pressure and professional expectations is stark — and it reflects a deeper tension in the stock’s story.
The Iridium Wildcard and the Neutron Clock
The real source of investor anxiety isn’t the Space Force deal at all. In late June, Rocket Lab announced a binding agreement to acquire Iridium Communications in a cash-and-stock transaction valuing the satellite operator at an enterprise value of roughly $8.0 billion. Strategically, the move transforms Rocket Lab into a vertically integrated space company with its own low-earth-orbit constellation. Tactically, it introduced a wave of uncertainty that has weighed heavily on the stock.
Then there’s Neutron. The larger launch vehicle, widely seen as the key to Rocket Lab’s transition from a pure launch provider to a diversified aerospace player, has seen its maiden flight pushed back to 2026. Some market observers have begun calling it a “test trap” — forcing investors to weigh steady suborbital revenue against the capital-intensive development of a medium-lift rocket. Rocket Lab posted an operating loss of $229 million in 2025, even as first-quarter 2026 revenue climbed 63.5% year-over-year to $200.3 million. The consensus for the second quarter, due August 10, calls for a loss of $0.07 per share on revenue of roughly $231.79 million.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
Compared to peers struggling with massive operating losses and sector-wide valuation hangovers — SpaceX has shed 51% from its highs and faces looming lockup expirations — Rocket Lab’s pivot toward hard-nosed defense contracts looks increasingly like a deliberate counterprogramming strategy. The Alaska deal provides the most tangible evidence yet that the Pentagon sees the company as a long-term infrastructure partner, not just a niche launch provider.
Whether the Iridium integration and Neutron’s first flight can deliver a similar vote of confidence is a question that won’t be answered until next year at the earliest. For now, Rocket Lab offers investors a study in contrasts: a stock in technical distress and a business embedding itself ever deeper into America’s national security architecture.
Ad
Rocket Lab Stock: New Analysis - 28 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
